(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 1.49% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.21%.
Adapthealth's revenue in 2026 is $3,226,709,000.On average, 10 Wall Street analysts forecast AHCO's revenue for 2026 to be $411,077,750,940, with the lowest AHCO revenue forecast at $382,172,781,388, and the highest AHCO revenue forecast at $501,337,608,692. On average, 10 Wall Street analysts forecast AHCO's revenue for 2027 to be $428,257,119,636, with the lowest AHCO revenue forecast at $379,309,553,272, and the highest AHCO revenue forecast at $533,651,183,144.
In 2028, AHCO is forecast to generate $464,797,364,164 in revenue, with the lowest revenue forecast at $396,352,577,772 and the highest revenue forecast at $567,464,543,752.